Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01FQV
|
|||
| Former ID |
DIB007174
|
|||
| Drug Name |
Dichloroacetate sodium
|
|||
| Synonyms |
Dichloroacetate sodium (pulmonary arterial hypertension), University of Alberta/Imperial College London
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Pulmonary hypertension [ICD-11: BB01; ICD-10: I27, I27.0; ICD-9: 416] | Phase 1 | [1] | |
| Company |
University of Alberta
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C2HCl2NaO2
|
|||
| Canonical SMILES |
C(C(=O)[O-])(Cl)Cl.[Na+]
|
|||
| InChI |
1S/C2H2Cl2O2.Na/c3-1(4)2(5)6;/h1H,(H,5,6);/q;+1/p-1
|
|||
| InChIKey |
LUPNKHXLFSSUGS-UHFFFAOYSA-M
|
|||
| CAS Number |
CAS 2156-56-1
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01083524) Dichloroacetate (DCA) for the Treatment of Pulmonary Arterial Hypertension. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.